We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
LORAZEPAM-AFT (AFT Pharmaceuticals Pty Ltd)
Product name
LORAZEPAM-AFT
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
131 (255 working days)
Active ingredients
lorazepam
Registration type
New generic medicine
Indication
- Pre-operative medication
- Premedication for prolonged investigations
- The treatment of acute anxiety states, acute agitation
- The control of status epilepticus in adults, adolescents and children. (See Section 4.2 Dose and Method of Administration).